38 filings
6-K
ANL
Adlai Nortye Ltd.
23 May 24
Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024
9:42pm
S-8
ANL
Adlai Nortye Ltd.
13 May 24
Registration of securities for employees
4:29pm
20-F
2023 FY
ANL
Adlai Nortye Ltd.
19 Apr 24
Annual report (foreign)
4:08pm
6-K
ANL
Adlai Nortye Ltd.
2 Apr 24
Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development
6:20am
424B4
ANL
Adlai Nortye Ltd.
29 Sep 23
Prospectus supplement with pricing info
4:01pm
EFFECT
h821n96 orwvys
29 Sep 23
Notice of effectiveness
12:15am
CERT
t4kf6 sww2edrrb7jlrj
28 Sep 23
Certification of approval for exchange listing
3:38pm
F-1/A
3v6jr2ixz
27 Sep 23
Registration statement (foreign) (amended)
12:28pm
CORRESP
glon1fq 7ti
27 Sep 23
Correspondence with SEC
12:00am
CORRESP
v4f6g1 c17
27 Sep 23
Correspondence with SEC
12:00am
CORRESP
cc0 ffoopvfti
27 Sep 23
Correspondence with SEC
12:00am
UPLOAD
b7gam3ok8nrnys9tjr
20 Sep 23
Letter from SEC
12:00am
F-1/A
wczdh2sx0y7rwqxsq6
12 Sep 23
Registration statement (foreign) (amended)
9:23am
CORRESP
emmlxiw79xow5b 6r25k
12 Sep 23
Correspondence with SEC
12:00am
8-A12B
w3kwgsv2p5llqcnuk
18 Aug 23
Registration of securities on exchange
1:16pm
UPLOAD
ww3wlliy0l
16 Aug 23
Letter from SEC
12:00am
F-1/A
6o9lfyribsj8jm6c hpx
14 Aug 23
Registration statement (foreign) (amended)
4:28pm
CORRESP
hokw88penw6mp1 azm8r
14 Aug 23
Correspondence with SEC
12:00am
F-1/A
jiuyfv
10 Aug 23
Registration statement (foreign) (amended)
4:08pm
CORRESP
u27ocf1u7g dux3l
10 Aug 23
Correspondence with SEC
12:00am